arrow
K

Keren Middelkoop

University of Cape Town
H指数:33
被引数:4,338

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety and immunogenicity of investigational tuberculosis vaccine M72/AS01E–4 in people living with HIV in South Africa: an observer-blinded, randomised, controlled, phase 2 trial

南非人类免疫缺陷病毒感染者中试验性结核病疫苗M72/AS01E–4的安全性及免疫原性:一项观察者盲法、随机对照、II期试验

2025-07-010
OAAI
Influence of vitamin D supplementation on muscle strength and exercise capacity in South African schoolchildren: secondary outcomes from a randomised controlled trial (ViDiKids)

补充维生素d对南非学龄儿童肌肉力量和运动能力的影响: 一项随机对照试验 (ViDiKids) 的次要结果

2024-09-261
OAAI
Influence of vitamin D supplementation on bone mineral content, bone turnover markers, and fracture risk in South African schoolchildren: multicenter double-blind randomized placebo-controlled trial (ViDiKids)

补充维生素d对南非学龄儿童骨矿物质含量,骨转换标志物和骨折风险的影响: 多中心双盲随机安慰剂对照试验 (ViDiKids)

2024-01-107
OAAI
Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial
2023-11-015
OAAI
HIV RNA Screening Reduces Integrase Strand Transfer Inhibitor Resistance Risk in Persons Receiving Long-Acting Cabotegravir for HIV Prevention
2022-10-1424
OA
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
2021-08-12443
OA
Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083
2021-03-1984
OA
A phase lb randomized study of the safety and immunological responses to vaccination with H4:IC31, H56:IC31, and BCG revaccination in Mycobacterium tuberculosis-uninfected adolescents in Cape Town, South Africa
2020-04-0146
OAAI